drugset / Trial / NCT00650949
Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
NaSingle-groupOpen-labelTreatment
Summary
This study seeks to (i) determine the safe dose of CYT997 when given in combination with carboplatin in patients with relapsed glioblastoma multiforme (glioma) and (ii) to determine whether the combination of CYT997 with carboplatin is a useful treatment for glioma.
Timeline
- Start
- 2009-11
- Primary completion
- 2011-06
- Completion
- 2011-06
Outcome
Outcome not reported
Stopped (Business): “Strategic”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 5 unknown | Intravenous |
| Subject | LEXIBULIN | Small molecule | 100 mg/m2 | Intravenous |
| Subject | LEXIBULIN | Small molecule | 150 mg/m2 | Intravenous |